Effectiveness of probiotics in the treatment of children with chronic abdominal pain and small intestinal bacterial overgrowth. A randomized placebo-controlled trial. - SIBO study

Jeroen Bosch Ziekenhuis0 个研究点目标入组 15 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•Children aged 8-18 years are included if they meet the criteria for functional dyspepsia, IBS, functional abdominal pain (FAP) or abdominal migraine, based on the Rome III Criteria for Functional Bowel Disorders Associated with Abdominal Pain or Discomfort in Children and have small intestinal bacterial overgrowth, diagnosed on hydrogen breath test as a fasting breath hydrogen concentration > 20 ppm or an increase of H2 levels of > 12 p.p.m. over the baseline value after ingestion of glucose.

•Children with abdominal pain as result of inflammatory, anatomic, metabolic or neoplastic disease. Children who were prescribed antibiotics or probiotics in the last month. Children who are critically ill or admitted at the ICU. Children who receive feeding via a tube.

发起方

Jeroen Bosch Ziekenhuis